Detalhe da pesquisa
1.
Unraveling the Effect of a Potentiating Anti-Factor H Antibody on Atypical Hemolytic Uremic Syndrome-Associated Factor H Variants.
J Immunol
; 205(7): 1778-1786, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32848031
2.
Functional Attributes of Antibodies, Effector Cells, and Target Cells Affecting NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity.
J Immunol
; 203(12): 3126-3135, 2019 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31748349
3.
Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation.
PLoS Pathog
; 14(5): e1007024, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29718999
4.
Enhanced Effector Functions Due to Antibody Defucosylation Depend on the Effector Cell Fcγ Receptor Profile.
J Immunol
; 199(1): 204-211, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28566370
5.
Rheumatoid factors do not preferentially bind to ACPA-IgG or IgG with altered galactosylation.
Rheumatology (Oxford)
; 56(11): 2025-2030, 2017 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28977504
6.
Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3).
Mol Cell Proteomics
; 14(5): 1373-84, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25759508
7.
Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia.
Br J Haematol
; 174(2): 310-20, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27017954
8.
Molecular evolution of broadly neutralizing Llama antibodies to the CD4-binding site of HIV-1.
PLoS Pathog
; 10(12): e1004552, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25522326
9.
Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages.
Blood
; 124(25): 3709-18, 2014 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25352126
10.
Rheumatoid factors do not preferentially bind to ACPA-IgG or IgG with altered galactosylation.
Rheumatology (Oxford)
; 57(4): 771, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29481646
11.
Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions.
Front Immunol
; 13: 1091668, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36483568
12.
Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions.
Front Immunol
; 13: 893648, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35651621
13.
Biophysical Evaluation of Rhesus Macaque Fc Gamma Receptors Reveals Similar IgG Fc Glycoform Preferences to Human Receptors.
Front Immunol
; 12: 754710, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34712242
14.
Author Correction: Human DC-SIGN and CD23 do not interact with human IgG.
Sci Rep
; 10(1): 12560, 2020 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32703963
15.
IgG Subclass Determines Suppression Versus Enhancement of Humoral Alloimmunity to Kell RBC Antigens in Mice.
Front Immunol
; 11: 1516, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32765523
16.
Human DC-SIGN and CD23 do not interact with human IgG.
Sci Rep
; 9(1): 9995, 2019 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292524
17.
Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune Diseases.
Front Immunol
; 9: 553, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29616041
18.
IgG Glyco-Engineering to Improve IVIg Potency.
Front Immunol
; 9: 2442, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30405631
19.
Conserved FcγR- glycan discriminates between fucosylated and afucosylated IgG in humans and mice.
Mol Immunol
; 94: 54-60, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29268168
20.
Affinity of human IgG subclasses to mouse Fc gamma receptors.
MAbs
; 9(5): 767-773, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28463043